Dr.
Hainsworth is board certified in Medical Oncology and has been with
Tennessee Oncology since 1993. He is currently the Director of Clinical
Research at the Sarah Cannon Cancer Center in Nashville, TN.
Dr.
Hainsworth received a Bachelor of Arts degree from Stanford University,
followed by a medical degree from Vanderbilt University. After completing
an internal medicine residency and a medical oncology fellowship, Dr.
Hainsworth remained at Vanderbilt as a faculty member in the Oncology
Division from 1981 - 1993.
Dr.
Hainsworth has a wide variety of clinical research interests and has
published extensively in the areas of lung cancer, unknown primary cancer,
breast cancer, and lymphoma. Recent work has resulted in expanded roles
and innovative uses for several new drugs including Paclitaxel, Docetaxel,
Gemcitabine, and Rituximab.